EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Gene replacement‐Alzheimer's disease (GR‐AD): Modeling the genetics of human dementias in mice

Kellie Benzow, Kul Karanjeet, Adrian L Oblak, Gregory W Carter, Michael Sasner, Michael D Koob

Alzheimer's & Dementia · 2024-04 · 20 (4) · 3080-3087

DOI: 10.1002/alz.13730 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 11.02.2024. Verfasst von Kellie Benzow und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine and Pathology, and Institute for Translational Neuroscience University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Genetic studies conducted over the past four decades have provided us with a detailed catalog of genes that play critical roles in the etiology of Alzheimer's disease (AD) and related dementias (ADRDs). Despite this progress, as a field we have had only limited success in incorporating this rich complexity of human AD/ADRD genetics findings into our animal models of these diseases. Our primary goal for the gene replacement (GR)‐AD project is to develop mouse lines that model the genetics of AD/ADRD as closely as possible. METHODS To do this, we are generating mouse lines in which the genes of interest are precisely and completely replaced in the mouse genome by their full human orthologs. RESULTS Each model set consists of a control line with a wild‐type human allele and variant lines that precisely match the human genomic sequence in the control line except for a high‐impact pathogenic mutation or risk variant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansAnimalsMicetau ProteinsMutationPresenilin-1Amyloid beta-Protein Precursor

Stichwörter der Autor:innen

APOE‐GRAPP‐GRC9ORF72‐GRMAPT‐GRPSEN1‐GRPSEN2‐GRSNCA‐GRTARDBP‐GRTMEM106B‐GRTREM2‐GRfunctional sequence variantgene‐replacement mouse modelprotective haplotyperisk haplotype

Substanzen

tau ProteinsPresenilin-1Amyloid beta-Protein Precursor

Autor:innen und Institutionen

  • Laboratory Medicine and Pathology, and Institute for Translational Neuroscience University of Minnesota, Minneapolis, Minnesota, USA.
  • Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • The Jackson Laboratory, Bar Harbor, Maine, USA.

Förderung

  • NINDS NIH HHS
  • NIH HHS
  • NIA NIH HHS
  • National Institute on Aging
  • National Institutes of Health

Zitieren

APA

Benzow, K., Karanjeet, K., Oblak, A. L., Carter, G. W., Sasner, M., & Koob, M. D. (2024). Gene replacement‐Alzheimer's disease (GR‐AD): Modeling the genetics of human dementias in mice. Alzheimer's & Dementia, 20(4), 3080-3087. https://doi.org/10.1002/alz.13730

Vancouver

Benzow K, Karanjeet K, Oblak AL, Carter GW, Sasner M, Koob MD. Gene replacement‐Alzheimer's disease (GR‐AD): Modeling the genetics of human dementias in mice. Alzheimer's & Dementia. 2024;20(4):3080-3087. doi:10.1002/alz.13730

BibTeX
@article{Benzow2024,
  author = {Benzow, Kellie and Karanjeet, Kul and Oblak, Adrian L and Carter, Gregory W and Sasner, Michael and Koob, Michael D},
  title = {Gene replacement‐Alzheimer's disease (GR‐AD): Modeling the genetics of human dementias in mice},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {4},
  pages = {3080--3087},
  doi = {10.1002/alz.13730}
}
Kostenlos starten →